Hankyel Park

Array ( [id] => 1532036 [patent_doc_number] => 06410298 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Adenovirus vectors and method for reducing homologous recombination phenomena' [patent_app_type] => B1 [patent_app_number] => 09/530378 [patent_app_country] => US [patent_app_date] => 2000-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11377 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410298.pdf [firstpage_image] =>[orig_patent_app_number] => 09530378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520509 [patent_doc_number] => 06413746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Production of proteins by cell culture' [patent_app_type] => B1 [patent_app_number] => 09/659764 [patent_app_country] => US [patent_app_date] => 2000-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5066 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413746.pdf [firstpage_image] =>[orig_patent_app_number] => 09659764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1532128 [patent_doc_number] => 06410318 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Antibodies directed against binding-associated epitopes' [patent_app_type] => B1 [patent_app_number] => 09/645648 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 5523 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410318.pdf [firstpage_image] =>[orig_patent_app_number] => 09645648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324078 [patent_doc_number] => 06329202 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Antibodies directed against binding associated epitopes' [patent_app_type] => 1 [patent_app_number] => 9/645122 [patent_app_country] => US [patent_app_date] => 2000-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 5455 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329202.pdf [firstpage_image] =>[orig_patent_app_number] => 645122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1423722 [patent_doc_number] => 06503753 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-07 [patent_title] => 'Method for the development of an HIV vaccine' [patent_app_type] => B1 [patent_app_number] => 09/638833 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14954 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/503/06503753.pdf [firstpage_image] =>[orig_patent_app_number] => 09638833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1584897 [patent_doc_number] => 06358696 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Methods of treatment of eye trauma and disorders' [patent_app_type] => B1 [patent_app_number] => 09/635309 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22801 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358696.pdf [firstpage_image] =>[orig_patent_app_number] => 09635309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1599886 [patent_doc_number] => 06475756 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Development of viruses resistant to inactivation by the human complement system' [patent_app_type] => B1 [patent_app_number] => 09/554838 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2702 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475756.pdf [firstpage_image] =>[orig_patent_app_number] => 09554838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1447304 [patent_doc_number] => 06369206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Metal organothiol particles' [patent_app_type] => B1 [patent_app_number] => 09/619343 [patent_app_country] => US [patent_app_date] => 2000-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19446 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369206.pdf [firstpage_image] =>[orig_patent_app_number] => 09619343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370375 [patent_doc_number] => 06274722 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Expression of a foamy virus envelope protein' [patent_app_type] => 1 [patent_app_number] => 9/617917 [patent_app_country] => US [patent_app_date] => 2000-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6947 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274722.pdf [firstpage_image] =>[orig_patent_app_number] => 617917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1388710 [patent_doc_number] => 06544785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Helper-free rescue of recombinant negative strand RNA viruses' [patent_app_type] => B1 [patent_app_number] => 09/616527 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22820 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544785.pdf [firstpage_image] =>[orig_patent_app_number] => 09616527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1439848 [patent_doc_number] => 06495347 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-17 [patent_title] => 'Induction of a Th1-like response in vitro' [patent_app_type] => B1 [patent_app_number] => 09/613303 [patent_app_country] => US [patent_app_date] => 2000-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 39 [patent_no_of_words] => 42771 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495347.pdf [firstpage_image] =>[orig_patent_app_number] => 09613303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4269150 [patent_doc_number] => 06322967 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Recombinant tryptophan mutants of influenza' [patent_app_type] => 1 [patent_app_number] => 9/612991 [patent_app_country] => US [patent_app_date] => 2000-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12592 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/322/06322967.pdf [firstpage_image] =>[orig_patent_app_number] => 612991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1514303 [patent_doc_number] => 06420139 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae' [patent_app_type] => B1 [patent_app_number] => 09/611415 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27731 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/420/06420139.pdf [firstpage_image] =>[orig_patent_app_number] => 09611415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1172058 [patent_doc_number] => 06750040 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Cell-free synthesis of polyketides' [patent_app_type] => B1 [patent_app_number] => 09/602725 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 17269 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750040.pdf [firstpage_image] =>[orig_patent_app_number] => 09602725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1365520 [patent_doc_number] => 06566095 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Compositions and methods for preventing transepithelial transmission of HIV' [patent_app_type] => B1 [patent_app_number] => 09/599555 [patent_app_country] => US [patent_app_date] => 2000-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 8012 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566095.pdf [firstpage_image] =>[orig_patent_app_number] => 09599555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391345 [patent_doc_number] => 06548643 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Antigen carbohydrate compounds and their use in immunotherapy' [patent_app_type] => B1 [patent_app_number] => 09/593870 [patent_app_country] => US [patent_app_date] => 2000-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 33 [patent_no_of_words] => 23568 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548643.pdf [firstpage_image] =>[orig_patent_app_number] => 09593870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317868 [patent_doc_number] => 06605449 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Synthetic ligation reassembly in directed evolution' [patent_app_type] => B1 [patent_app_number] => 09/594459 [patent_app_country] => US [patent_app_date] => 2000-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 57091 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605449.pdf [firstpage_image] =>[orig_patent_app_number] => 09594459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500046 [patent_doc_number] => 06485965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Replicating or semi-replicating viral constructs, preparation and uses for gene delivery' [patent_app_type] => B1 [patent_app_number] => 09/589783 [patent_app_country] => US [patent_app_date] => 2000-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 16334 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485965.pdf [firstpage_image] =>[orig_patent_app_number] => 09589783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594945 [patent_doc_number] => 06492128 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Drug screen targeting lipoprotein-membrane anchorage' [patent_app_type] => B1 [patent_app_number] => 09/555871 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 25 [patent_no_of_words] => 16720 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492128.pdf [firstpage_image] =>[orig_patent_app_number] => 09555871 [rel_patent_id] =>[rel_patent_doc_number] =>)